2022. Mavacamten and the Reframing of Obstructive Hypertrophic Cardiomyopathy as a Medically Treatable Disease. Journal of Heart and Cardiovascular Science. 3, 1 (Oct. 2022), 16–21. DOI:https://doi.org/10.5281/zenodo.22344598.